（文章来源：证券日报） 证券日报网讯 2月24日，岩山科技在互动平台回答投资者提问时表示，截至目前，公司与宇树科技无合 作关系。敬请广大投资者理性辨别网传信息，避免因不实信息造成误导。 ...

据交易所数据显示，截至2月24日午间收盘，大盘主力资金净流入122.98亿元。主力资金流出前十大板块分别为：计算机（-97.10亿元）、 传媒（-62.07亿 元）、IT服务Ⅱ（-48.08亿元）、IT服务Ⅲ（-48.08亿元）、 软件开发（-42.16亿元）、垂直 应用软件（-23.26亿元）、 影视院线（-21.46亿元）、横向通用 软件（-18.89亿元）、影视动漫制作（-18.73亿元）、 广告营销（-16.86亿元）。 | 影视院线 | -7.25 | -21.46亿元 | 华谊兄弟 | | --- | --- | --- | --- | | 横向通用软 件 | -4.26 | -18.89亿元 | 亚信安全 | | 影视动漫制 | -6.1 | -18.73亿元 | 华谊兄弟 | | 作 | | | | | 广告营销 | -1.57 | -16.86亿元 | 佳云科技 | | *数据仅供参考，不构成投资建议 | | | | | | 板块名称 涨跌幅(%) 板块资金流向 | | 净流出最大 | | --- | --- | --- | --- | | 计算机 | -0.77 | -97.10亿元 | ...

截至减持股份计划公告披露前最后一个交易日，即2026年2月12日，岩山科技收报10.18元/股，以此计 算，陈于冰本次减持金额预计为16,969.55万元，黄国敏本次减持金额预计为237.80万元。 截至目前，岩山科技副董事长、总经理陈于冰持有岩山科技股份66,678,039股，占岩山科技当前总股本 5,670,554,696股的比例为1.1759%。 中国经济网北京2月13日讯 岩山科技(002195.SZ)昨日晚间发布公告称，近日，公司收到董事、高级管理 人员陈于冰及高级管理人员黄国敏分别出具的《减持计划告知函》。 陈于冰计划在公告披露之日起15个交易日后的三个月内（即自2026年3月16日起至2026年6月15日止，根 据法律法规禁止减持的期间除外）以大宗交易和/或集中竞价方式合计减持上市公司股份不超过 16,669,500股（约占上市公司总股本比例0.2940%）。 黄国敏计划在公告披露之日起15个交易日后的三个月内（即自2026年3月16日起至2026年6月15日止，根 据法律法规禁止减持的期间除外）以大宗交易和/或集中竞价方式合计减持上市公司股份不超过233,600 股（约占上市公司总股本比例0. ...

Core Viewpoint - The company, Yanshan Technology (002195.SZ), announced plans for share reductions by its executives, indicating potential changes in insider ownership and market sentiment [1] Group 1: Share Reduction Plans - Executive Chen Yubing plans to reduce his holdings by up to 16.6695 million shares, representing approximately 0.2940% of the company's total share capital, within a three-month period starting from March 16, 2026 [1] - Executive Huang Guomin intends to reduce his holdings by up to 233,600 shares, which accounts for about 0.0041% of the company's total share capital, also within the same three-month timeframe [1]

证券代码：002195 证券简称：岩山科技 公告编号：2026-008 上海岩山科技股份有限公司 董事、高级管理人员减持股份预披露公告 董事、高级管理人员陈于冰先生、高级管理人员黄国敏先生保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示：持有上海岩山科技股份有限公司（以下简称"公司"或"本公司"） 股份 66,678,039 股（占本公司总股本比例 1.1759%）的董事、高级管理人员陈于 冰先生计划在本公告披露之日起 15 个交易日后的三个月内（即自 2026 年 3 月 16 日起至 2026 年 6 月 15 日止，根据法律法规禁止减持的期间除外）以大宗交易和/ 或集中竞价方式合计减持本公司股份不超过 16,669,500 股（约占本公司总股本比 例 0.2940%）。 持有本公司股份 934,440 股（占本公司总股本比例 0.0165%）的高级管理人员 黄国敏先生计划在本公告披露之日起 15 个交易日后的三个月内（即自 2026 年 3 月 16 日起至 2026 年 6 月 15 日止， ...

Core Viewpoint - The announcement from Rock Mountain Technology indicates planned share reductions by key executives, which may impact investor sentiment and stock performance in the near term [1]. Group 1: Share Reduction Plans - Executive Chen Yubing plans to reduce his holdings by up to approximately 16.67 million shares, representing about 0.2940% of the company's total share capital, within a three-month period starting from March 16, 2026 [1]. - Executive Huang Guomin intends to reduce his holdings by up to approximately 230,000 shares, accounting for about 0.0041% of the company's total share capital, also within the same three-month period starting from March 16, 2026 [1]. Group 2: Investment Activity - Notable investors Ge Weidong and Fang Wenyuan have jointly invested 1 billion yuan each in the company, leading to a significant increase in the company's stock price [1].

Group 1 - The company announced that its Vice Chairman and General Manager, Chen Yubing, holds 66.678 million shares, accounting for 1.1759% of total shares, and plans to reduce his holdings by up to 16.6695 million shares, representing 0.2940%, through block trades and/or centralized bidding from March 16, 2026, to June 15, 2026 [1] - The company's Vice General Manager and Chief Financial Officer, Huang Guomin, holds 0.9344 million shares, which is 0.0165% of total shares, and intends to reduce his holdings by up to 0.2336 million shares, or 0.0041%, during the same period using similar methods [1]

Group 1 - The core viewpoint of the article highlights the increasing investment and research activity in the brain-computer interface (BCI) industry in China, with a focus on key companies and patent trends [1][4][5] Group 2 - The research and development investment in the BCI industry by listed companies in China is steadily increasing from 2020 to 2024, indicating a strengthening of R&D efforts [1] - The number of patent applications in China's BCI industry showed a steady growth trend, peaking at 258 applications in 2021, followed by a decrease to 209 applications in 2024 [4] - Tianjin University is identified as the leading patent applicant in the BCI sector, with a total of 126 related patents, followed by South China University of Technology and Xi'an Jiaotong University with 80 and 78 patents respectively [5][7] - The most popular technology patents in the BCI industry are in the category of electrical digital data processing (G06F), with a total of 1,013 patents, followed by diagnostic and surgical technologies (A61B) with 712 patents, and specific computing models (G06N) with 313 patents [8]

Group 1: Innovation in Medical Technology - Innovation Medical (002173) has established itself in the medical service sector, focusing on brain-computer interface (BCI) technology for clinical applications, particularly in neuro-rehabilitation and cardiovascular treatment [1][20] - The company's BCI-4000 product is in Phase III clinical trials, utilizing invasive electrodes to collect brain signals for device control, aiding rehabilitation for high-level paraplegics [1][20] - With the implementation of insurance reimbursement policies for BCI, the clinical transition process is expected to accelerate, potentially leading to significant growth in the neuro-rehabilitation business [1][20] Group 2: Digital Entertainment and AI Integration - Talking Tom (300459) leverages its popular IPs in digital entertainment and is actively exploring the integration of AI with brain-computer interfaces to create immersive interactive experiences [2][21] - The core business includes IP operation, mobile app development, and digital content creation, focusing on leisure and children's education [2][21] - The company aims to develop brain-controlled games and immersive entertainment applications, enhancing user engagement and monetization capabilities [2][21] Group 3: Precision Components in Medical Devices - Meihua Medical (301363) specializes in manufacturing precision medical components, providing essential support to global medical device companies, and has recently entered the brain-computer interface supply chain [3][22] - The company produces components for cardiovascular and neuro-interventional devices, including precision structural parts for BCI equipment [3][22] - As demand for BCI devices increases, the company anticipates a steady growth in orders for precision components, enhancing collaboration with BCI firms [3][22] Group 4: AI and Brain-Computer Interface Algorithms - Yanshan Technology (002195) focuses on brain-like intelligence and AI, with a strong emphasis on developing neural signal decoding algorithms for brain-computer interfaces [4][23] - The company aims to optimize brain signal decoding efficiency through AI algorithms, enhancing the precision control capabilities of BCI devices [4][23] - As the demand for algorithm precision in BCI increases, the company expects growth in algorithm licensing and system integration services [4][23] Group 5: Network Solutions for Brain-Computer Interfaces - StarNet Ruijie (002396) is a leading provider of network equipment and solutions, exploring network support solutions for brain-computer interface applications [5][25] - The company offers high-speed data transmission and processing solutions for BCI devices, facilitating real-time brain signal transmission and cloud analysis [5][25] - With the rising demand for data transmission efficiency in BCI, the company anticipates continued growth in high-speed network equipment demand [5][25] Group 6: Pain Management and Neuroregulation - Aipeng Medical (300753) specializes in pain management and neuroregulation, exploring the application of brain-computer interfaces in postoperative pain relief and neuro-rehabilitation [6][26] - The company focuses on developing devices for pain management and neuroregulation, aiming to enhance treatment efficiency through brain-computer technology [6][26] - As the demand for neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [6][26] Group 7: Security and Identity Verification - Entropy Technology (301330) leverages biometric recognition and identity verification technologies, applying brain-computer interfaces in security and identity authentication [7][27] - The company provides solutions for financial, governmental, and transportation sectors, focusing on the development of BCI applications for secure interactions [7][27] - As the demand for precision and security in identity verification increases, the potential for BCI applications in security will gradually be realized [7][27] Group 8: Smart Control Components and IoT Solutions - Yingqu Technology (002925) specializes in smart control components and IoT solutions, providing essential support for brain-computer interface devices [8][28] - The company serves consumer electronics and smart home sectors, offering smart control components that facilitate intelligent interaction and data collection for BCI devices [8][28] - With the rising demand for intelligent BCI devices, the company expects a continuous increase in orders for smart control components [8][28] Group 9: Precious Metal Materials for BCI Electrodes - Guiyan Platinum (600459) focuses on the research and production of precious metal materials, providing critical materials for brain-computer interface electrodes [9][29] - The company supplies platinum-based alloy materials that enhance the biocompatibility and signal stability of BCI electrodes [9][29] - As the demand for mass production of BCI electrodes increases, the company anticipates a steady growth in orders for precious metal materials [9][29] Group 10: Automotive Applications of Brain-Computer Interfaces - Yachuang Electronics (301099) is exploring the application of brain-computer interfaces in smart driving, focusing on automotive-grade chips and power semiconductors [10][30] - The company aims to implement brain control technology for vehicle operation, opening new possibilities in automotive intelligence [10][30] - As the demand for human-machine interaction in smart driving increases, the potential for BCI applications in the automotive sector will gradually be realized [10][30] Group 11: Industrial Applications of Brain-Computer Interfaces - Zhongke Information (300678) focuses on intelligent monitoring and industrial detection, applying brain-computer interfaces in industrial settings [11][31] - The company aims to utilize brain signals for equipment status monitoring and fault prediction, enhancing industrial efficiency [11][31] - As the demand for monitoring precision in industrial automation increases, the application of BCI in industrial settings is expected to accelerate [11][31] Group 12: Third-Party Testing for BCI Compliance - Puni Testing (300887) is a leading third-party testing organization, providing compliance testing services for brain-computer interface devices [12][32] - The company offers testing for biocompatibility and electromagnetic compatibility, ensuring the safety and compliance of BCI products [12][32] - As the BCI industry matures, the demand for compliance testing services is expected to grow, supporting the healthy development of the industry [12][32] Group 13: Flexible Materials for BCI Devices - Pulit (002324) specializes in the research and production of polymer materials, providing essential flexible packaging materials for brain-computer interface devices [13][33] - The company enhances the durability and biocompatibility of BCI devices through its flexible packaging solutions [13][33] - As the demand for flexible materials in BCI devices increases, the company anticipates a steady growth in orders for packaging materials [13][33] Group 14: Intelligent Equipment and Robotics - Tianqi Co., Ltd. (002009) focuses on intelligent equipment manufacturing and industrial automation, exploring the application of brain-computer interfaces in industrial robotics [14][34] - The company aims to implement brain control technology for precise robotic operation, enhancing manufacturing efficiency [14][34] - As the demand for precision in industrial automation increases, the application of BCI in robotics is expected to accelerate [14][34] Group 15: Medical Rehabilitation and Training - Chengyitong (300430) specializes in pharmaceutical intelligent manufacturing and rehabilitation equipment, exploring the application of brain-computer interfaces in rehabilitation training [15][35] - The company focuses on optimizing rehabilitation plans through brain control technology, enhancing training efficiency [15][35] - As the demand for neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [15][35] Group 16: Military Communication and Navigation - Haige Communication (002465) is a core enterprise in military communication and navigation, providing specialized support for brain-computer interfaces [16][36] - The company offers military communication and data transmission solutions for BCI devices, enhancing interaction in specialized scenarios [16][36] - As the demand for BCI in military applications increases, the need for communication equipment is expected to grow [16][36] Group 17: Smart Terminals and Information Systems - Nanjing Panda (600775) leverages electronic manufacturing and communication technology, exploring the application of brain-computer interfaces in smart terminals [17][37] - The company aims to implement brain control technology for device operation, opening new possibilities in consumer electronics [17][37] - As the demand for interactive methods in smart terminals increases, the potential for BCI applications in consumer electronics will gradually be realized [17][37] Group 18: Biocompatible Coatings for BCI Devices - Taihe Technology (300801) specializes in fine chemicals and water treatment materials, providing essential biocompatible coating materials for brain-computer interface devices [18][38] - The company enhances the safety and durability of BCI devices through its biocompatible coatings [18][38] - As the demand for biocompatibility in BCI devices increases, the company anticipates a steady growth in orders for coating materials [18][38] Group 19: Cardiovascular and Neurointerventional Applications - Lepu Medical (300003) focuses on cardiovascular and neurointerventional fields, exploring the application of brain-computer interfaces in cardiac rehabilitation and neuroregulation [19][39] - The company aims to optimize treatment plans through brain control technology, enhancing rehabilitation efficiency [19][39] - As the demand for cardiovascular and neuro-rehabilitation grows, the application of BCI in medical settings is expected to accelerate [19][39] Group 20: Intelligent Nursing and Patient Monitoring - Yahua Electronics (301337) specializes in medical information systems and intelligent nursing devices, exploring the application of brain-computer interfaces in patient monitoring [20][40] - The company aims to utilize brain signals for real-time patient status monitoring, enhancing medical service efficiency [20][40] - As the demand for precise monitoring in medical services increases, the application of BCI in healthcare settings is expected to accelerate [20][40]

Group 1 - A-share market AIGC concept stocks experienced a collective decline, with notable drops in several companies [1] - Zhejiang Wenlian fell by 9.09%, Kunlun Wanwei and Yue Media dropped over 7%, while Xuan Ya International and Tian Xia Xiu fell over 5% [1][2] - Other companies such as Zhongkong Technology and Zhi De Mai saw declines of over 4%, and several others fell by more than 3% [1] Group 2 - Zhejiang Wenlian's total market value is 21 billion, with a year-to-date increase of 80.43% [2] - Kunlun Wanwei has a market value of 68.8 billion, with a year-to-date increase of 31.37% [2] - Yue Media's market value stands at 13.1 billion, with a year-to-date increase of 31.21% [2]